Last reviewed · How we verify

NCT05631197

Biomimetic Hydroxyapatite in Pediatric Patients With Asthma and/or Allergic Rhinitis

Completed NA Last updated 8 November 2023
What this trial tests

NA trial testing Biorepair Total Protection Plus + desensitizing enamel-repair shock treatment in Dental Caries in 40 participants. Completed in 30 September 2023.

Timeline
2 March 2022
Primary endpoint
27 September 2023
30 September 2023

Quick facts

Lead sponsorUniversity of Pavia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment40
Start date2 March 2022
Primary completion27 September 2023
Estimated completion30 September 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Pavia

Who can join

Adults 6 to 14, any sex, with Dental Caries or Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare the incidence of dental caries and the level of demineralization in pediatric patients with asthma and/or allergic rhinitis. Patients will conduct professional oral hygiene at the baseline. The following clinical indexes will be assessed: BEWE Index, Plaque Index, Bleeding Score, Schiff Air Index. Then, patients will be randomly divided into two groups: * Trial group: domiciliary use of Biorepair Total Protection Plus + desensitizing enamel-repair shock treatment twice a day * Control group: domiciliary use of Elmex Caries Protection twice a day The clinical indexes will be assessed again after 1 month (T1), after 3 (T2) and 6 months (T3).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dental Caries

Currently open trials in the same condition.

Other University of Pavia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05631197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing